Delivery Order SPE2DB20D9332-SPE2DB24FV3A2
Award Date
12/7/23
Potential Completion Date
12/29/23
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 mg/ml syringes. The $123,792.00 delivery order has an estimated completion date of April 3, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various indefinite delivery contracts with DLA to supply a wide range of pharmaceutical and medical products to military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of XOLAIR 150 MG/ML syringes. The total ceiling value of the order is $77,370.00, with an ultimate completion date of September 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML syringes. The order has a potential value of $27,853.20 and a completion date of January 30, 2024. This order is placed against an existing indefinite delivery contract with DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical supplies to support military treatment facilities globally. DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML syringes and has a performance period through May 2, 2024. This award is placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, valued at up to $4,999,999 through 2025. Under this broader contract vehicle, DMS Pharmaceutical Group...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of XOLAIR 150 MG/ML syringes. This $9,284.40 contract has a completion date of May 24, 2024 and is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with DLA for pharmaceutical supplies supporting military health facilities. This contract has no set-aside designation. DMS Pharmaceutical Group is a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product XOLAIR 150 MG/ML SYRINGE. The contract has a potential value of $14,700.32 and a completion date of March 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that supplies a wide range of branded and generic pharmaceuticals to U.S. government agencies,...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGE ML. The contract has a potential value of $4,642.20 and a completion date of February 26, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued up to $4,999,999 through 2025, which...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGE/ML. The contract has a potential value of $21,663.60 and a completion date of January 24, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, primarily the Department of Defense, under...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGE/ML. This delivery order has a potential value of $3,094.80 and a completion date of January 24, 2024. DMS Pharmaceutical Group Inc. holds various federal contracts and indefinite delivery vehicles (IDVs) with the Defense Logistics Agency to supply pharmaceuticals and medical products in support of military treatment...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is to provide XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a potential value of $3,094.80 and a completion date of February 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds numerous contracts and indefinite delivery vehicles (IDVs) with DLA to supply a wide range of pharmaceuticals...